| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.5 | 8e-48 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.49 | 4e-45 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.46 | 1e-36 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.36 | 3e-34 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.37 | 2e-29 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.4 | 1e-27 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.37 | 1e-26 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.33 | 1e-24 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.33 | 1e-23 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.42 | 9e-23 |